{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T09:03:54Z","timestamp":1790154234418,"version":"4.0.1"},"reference-count":122,"publisher":"MDPI AG","issue":"19","license":[{"start":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:00:00Z","timestamp":1790121600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Medical University of Lodz","doi-asserted-by":"publisher","award":["503\/1-062-02\/503-11-001"],"award-info":[{"award-number":["503\/1-062-02\/503-11-001"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"publisher"}]},{"award":["503\/1-062-02\/503-11-001"],"award-info":[{"award-number":["503\/1-062-02\/503-11-001"]}],"id":[{"id":"https:\/\/ror.org\/02t4ekc95","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Mol. Sci.","IJMS"],"abstract":"<jats:p>Major depressive disorder (MDD) is a complex psychiatric condition whose pathophysiology extends beyond the classic monoamine hypothesis, involving impaired neuroplasticity, neuroinflammation, HPA axis dysregulation, and altered neurotrophic signaling. The fibroblast growth factor (FGF) system, comprising ligands and their receptors (FGFRs), has emerged as a key candidate regulator of these processes. This scoping review qualitatively synthesizes current clinical, postmortem, and preclinical evidence on the role of the FGF system in MDD and antidepressant response. A structured literature search according to PRISMA-ScR was conducted in PubMed\/MEDLINE and Scopus without date restrictions. Eligible studies included human (clinical, postmortem), preclinical, and translational data investigating FGF\/FGFR expression, signaling, manipulation, or peripheral biomarker associations in the context of depression or antidepressant action. Of 287 unique records screened, 68 met the inclusion criteria; together with 11 studies identified through backward citation searching, 79 studies were included in the qualitative synthesis. This synthesis outlines a bidirectional role for the fibroblast growth factor (FGF) system in major depressive disorder (MDD). Rather than acting as a uniform pathway, different FGF ligands exert opposing regulatory effects on mood, neuroplasticity, and stress responses. FGF-2 exerts protective and neurotrophic effects, while factors like FGF-9 act as endogenous prodepressants. Although circulating biomarkers show heterogeneity, central FGF\/FGFR signaling represents a promising target for novel therapeutic strategies and personalized treatment approaches in MDD.<\/jats:p>","DOI":"10.3390\/ijms27198464","type":"journal-article","created":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:14:39Z","timestamp":1790151279000},"page":"8464","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fibroblast Growth Factors and Their Receptors in Major Depressive Disorder: A Scoping Review of Translational Research"],"prefix":"10.3390","volume":"27","author":[{"given":"Gracja","family":"Ryznar","sequence":"first","affiliation":[{"name":"Department of Adult Psychiatry, Medical University of Lodz, 91-229 Lodz, Poland"},{"name":"International Doctoral School, Medical University of Lodz, 90-647 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2447-5636","authenticated-orcid":false,"given":"Piotr","family":"Ga\u0142ecki","sequence":"additional","affiliation":[{"name":"Department of Adult Psychiatry, Medical University of Lodz, 91-229 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9779-7057","authenticated-orcid":false,"given":"Katarzyna","family":"Bli\u017aniewska-Kowalska","sequence":"additional","affiliation":[{"name":"Department of Adult Psychiatry, Medical University of Lodz, 91-229 Lodz, Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,9,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1176\/appi.ajp.161.11.1957","article-title":"Hippocampal Volume and Depression: A Meta-Analysis of MRI Studies","volume":"161","author":"Videbech","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2376","DOI":"10.1038\/npp.2009.75","article-title":"Antidepressants increase neural progenitor cells in the human hippocampus","volume":"34","author":"Boldrini","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1038\/npp.2013.5","article-title":"Hippocampal granule neuron number and dentate gyrus volume in antidepressant-treated and untreated major depression","volume":"38","author":"Boldrini","year":"2013","journal-title":"Neuropsychopharmacology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.biopsych.2009.09.033","article-title":"A Meta-Analysis of Cytokines in Major Depression","volume":"67","author":"Dowlati","year":"2010","journal-title":"Biol. Psychiatry"},{"key":"ref_5","first-page":"171","article-title":"Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis","volume":"71","author":"Howren","year":"2009","journal-title":"Biopsychosoc. Sci. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S1461145709009924","article-title":"A potential role for pro-inflammatory cytokines in regulating synaptic plasticity in major depressive disorder","volume":"12","author":"Khairova","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0165-0327(00)00352-9","article-title":"Stress, hypercortisolism and corticosteroid receptors in depression: Implications for therapy","volume":"62","author":"Holsboer","year":"2001","journal-title":"J. Affect. Disord."},{"key":"ref_8","first-page":"151","article-title":"The Hypothalamic-Pituitary-Adrenal Axis in Major Depressive Disorder: A Brief Primer for Primary Care Physicians","volume":"3","author":"Varghese","year":"2001","journal-title":"Prim. Care Companion J. Clin. Psychiatry"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.biopsych.2006.02.013","article-title":"A neurotrophic model for stress-related mood disorders","volume":"59","author":"Duman","year":"2006","journal-title":"Biol. Psychiatry"},{"key":"ref_10","doi-asserted-by":"crossref","unstructured":"Deng, Z., Deng, S., Zhang, M.R., and Tang, M.M. (2019). Fibroblast Growth Factors in Depression. Front. Pharmacol., 10.","DOI":"10.3389\/fphar.2019.00060"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s43556-026-00429-0","article-title":"FGF family in health and disease","volume":"7","author":"Liu","year":"2026","journal-title":"Mol. Biomed."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1093\/jb\/mvq121","article-title":"Fibroblast growth factors: From molecular evolution to roles in development, metabolism and disease","volume":"149","author":"Itoh","year":"2011","journal-title":"J. Biochem."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"Reviews3005","DOI":"10.1186\/gb-2001-2-3-reviews3005","article-title":"Fibroblast growth factors","volume":"2","author":"Ornitz","year":"2001","journal-title":"Genome Biol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.tig.2004.08.007","article-title":"Evolution of the Fgf and Fgfr gene families","volume":"20","author":"Itoh","year":"2004","journal-title":"Trends Genet."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/wdev.176","article-title":"The Fibroblast Growth Factor signaling pathway","volume":"4","author":"Ornitz","year":"2015","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Phan, P., Saikia, B.B., Sonnaila, S., Agrawal, S., Alraawi, Z., Kumar, T.K.S., and Iyer, S. (2021). The Saga of Endocrine FGFs. Cells, 10.","DOI":"10.3390\/cells10092418"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/nrd.2015.9","article-title":"Therapeutic potential of the endocrine fibroblast growth factors FGF19, FGF21 and FGF23","volume":"15","author":"Degirolamo","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Itoh, N., Ohta, H., and Konishi, M. (2015). Endocrine FGFs: Evolution, Physiology, Pathophysiology, and Pharmacotherapy. Front. Endocrinol., 6.","DOI":"10.3389\/fendo.2015.00154"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrd2792","article-title":"The FGF family: Biology, pathophysiology and therapy","volume":"8","author":"Beenken","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/nrm3528","article-title":"Exploring mechanisms of FGF signalling through the lens of structural biology","volume":"14","author":"Goetz","year":"2013","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1073\/pnas.0307287101","article-title":"Insights into the molecular basis for fibroblast growth factor receptor autoinhibition and ligand-binding promiscuity","volume":"101","author":"Olsen","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1002\/jcp.24649","article-title":"Isoforms of receptors of fibroblast growth factors","volume":"229","author":"Gong","year":"2014","journal-title":"J. Cell Physiol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1073\/pnas.0436500100","article-title":"Structural basis by which alternative splicing confers specificity in fibroblast growth factor receptors","volume":"100","author":"Yeh","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41392-020-00222-7","article-title":"FGF\/FGFR signaling in health and disease","volume":"5","author":"Xie","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/nature25451","article-title":"\u03b1-Klotho is a non-enzymatic molecular scaffold for FGF23 hormone signalling","volume":"553","author":"Chen","year":"2018","journal-title":"Nature"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/S0006-3223(02)01363-X","article-title":"Astrocytic basic fibroblast growth factor expression in dopaminergic regions after perinatal anoxia","volume":"52","author":"Flores","year":"2002","journal-title":"Biol. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0306-4522(02)00060-X","article-title":"Chronic hypoxia up-regulates fibroblast growth factor ligands in the perinatal brain and induces fibroblast growth factor-responsive radial glial cells in the sub-ependymal zone","volume":"112","author":"Ganat","year":"2002","journal-title":"Neuroscience"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.biopsych.2006.10.019","article-title":"Fibroblast growth factor receptor-1 is required for long-term potentiation, memory consolidation, and neurogenesis","volume":"62","author":"Zhao","year":"2007","journal-title":"Biol. Psychiatry."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1046\/j.1440-1681.2001.03477.x","article-title":"Fibroblast growth factors in the developing central nervous system","volume":"28","author":"Abud","year":"2001","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e4563","DOI":"10.1097\/MD.0000000000004563","article-title":"Significantly higher peripheral fibroblast growth factor-2 levels in patients with major depressive disorder: A preliminary meta-analysis under MOOSE guidelines","volume":"95","author":"Wu","year":"2016","journal-title":"Medicine"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.euroneuro.2020.09.633","article-title":"Value of peripheral neurotrophin levels for the diagnosis of depression and response to treatment: A systematic review and meta-analysis","volume":"41","author":"Shi","year":"2020","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s12031-023-02101-6","article-title":"Fibroblast Growth Factor 2 Levels in Patients with Major Depressive Disorder: A Meta-analysis","volume":"73","author":"Wang","year":"2023","journal-title":"J. Mol. Neurosci."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.neulet.2014.07.035","article-title":"Decreased serum fibroblast growth factor\u20142 levels in pre- and post-treatment patients with major depressive disorder","volume":"579","author":"He","year":"2014","journal-title":"Neurosci. Lett."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.jad.2020.12.055","article-title":"Fibroblast Growth Factor 2 Implicated in Childhood Anxiety and Depression Symptoms","volume":"282","author":"Lebowitz","year":"2021","journal-title":"J. Affect. Disord."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.psyneuen.2008.09.016","article-title":"Angiogenic factors in patients with current major depressive disorder comorbid with borderline personality disorder","volume":"34","author":"Kahl","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.comppsych.2013.03.026","article-title":"Elevated specific peripheral cytokines found in major depressive disorder patients with childhood trauma exposure: A cytokine antibody array analysis","volume":"54","author":"Lu","year":"2013","journal-title":"Compr. Psychiatry"},{"key":"ref_37","first-page":"9130868","article-title":"Alterations in the Levels of Growth Factors in Adolescents with Major Depressive Disorder: A Longitudinal Study during the Treatment with Fluoxetine","volume":"19","author":"Arreola","year":"2019","journal-title":"Mediat. Inflamm."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jad.2023.01.090","article-title":"Maternal FGF2 levels associated with child anxiety and depression symptoms through child FGF2 levels","volume":"326","author":"Lebowitz","year":"2023","journal-title":"J. Affect. Disord."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.psychres.2018.12.084","article-title":"Epidermal growth factor and fibroblast growth factor-2 circulating levels in elderly with major depressive disorder","volume":"272","author":"Wu","year":"2019","journal-title":"Psychiatry Res."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1007\/s00702-010-0452-1","article-title":"Plasma levels of vascular endothelial growth factor and fibroblast growth factor 2 in patients with major depressive disorders","volume":"117","author":"Takebayashi","year":"2010","journal-title":"J. Neural. Transm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"24705470221114787","DOI":"10.1177\/24705470221114787","article-title":"The Association Between Salivary FGF2 and Physiological and Psychological Components of the Human Stress Response","volume":"6","author":"Bryant","year":"2022","journal-title":"Chronic Stress"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.brainresbull.2006.04.008","article-title":"Hippocampal FGF-2 and FGFR1 mRNA expression in major depression, schizophrenia and bipolar disorder","volume":"70","author":"Gaughran","year":"2006","journal-title":"Brain Res. Bull."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"15506","DOI":"10.1073\/pnas.0406788101","article-title":"Dysregulation of the fibroblast growth factor system in major depression","volume":"101","author":"Evans","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"11953","DOI":"10.1073\/pnas.1510456112","article-title":"Fibroblast growth factor 9 is a novel modulator of negative affect","volume":"112","author":"Aurbach","year":"2015","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.bbi.2017.05.013","article-title":"Exogenous FGF2 reverses depressive-like behaviors and restores the suppressed FGF2-ERK1\/2 signaling and the impaired hippocampal neurogenesis induced by neuroinflammation","volume":"66","author":"Tang","year":"2017","journal-title":"Brain Behav. Immun."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"173297","DOI":"10.1016\/j.ejphar.2020.173297","article-title":"Involvement of FGF-2 modulation in the antidepressant-like effects of liquiritin in mice","volume":"881","author":"Chen","year":"2020","journal-title":"Eur. J. Pharmacol."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.brainresbull.2022.02.020","article-title":"High-frequency repetitive transcranial magnetic stimulation mitigates depression-like behaviors in CUMS-induced rats via FGF2\/FGFR1\/p-ERK signaling pathway","volume":"183","author":"Yan","year":"2022","journal-title":"Brain Res. Bull."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/mp.2014.136","article-title":"Neurotrophic factor-\u03b11 prevents stress-induced depression through enhancement of neurogenesis and is activated by rosiglitazone","volume":"20","author":"Cheng","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"159","DOI":"10.3892\/etm.2014.1674","article-title":"Monoamine neurotransmitters and fibroblast growth factor-2 in the brains of rats with post-stroke depression","volume":"8","author":"Ji","year":"2014","journal-title":"Exp. Ther. Med."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"101872","DOI":"10.1016\/j.jchemneu.2020.101872","article-title":"MiR-497 promotes microglia activation and proinflammatory cytokines production in chronic unpredictable stress-induced depression via targeting FGF2","volume":"110","author":"Zhai","year":"2020","journal-title":"J. Chem. Neuroanat."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.neuropharm.2008.07.014","article-title":"Chronic antidepressant treatments increase basic fibroblast growth factor and fibroblast growth factor-binding protein in neurons","volume":"55","author":"Bachis","year":"2008","journal-title":"Neuropharmacology"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.biopsych.2004.02.003","article-title":"Fluoxetine and olanzapine have synergistic effects in the modulation of fibroblast growth factor 2 expression within the rat brain","volume":"55","author":"Maragnoli","year":"2004","journal-title":"Biol. Psychiatry"},{"key":"ref_53","doi-asserted-by":"crossref","unstructured":"Carboni, L., Rullo, L., Caputi, F.F., Stamatakos, S., Candeletti, S., and Romualdi, P. (2022). Chronic Trazodone and Citalopram Treatments Increase Trophic Factor and Circadian Rhythm Gene Expression in Rat Brain Regions Relevant for Antidepressant Efficacy. Int. J. Mol. Sci., 23.","DOI":"10.3390\/ijms232214041"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.brainres.2007.08.045","article-title":"Vagus nerve stimulation increases norepinephrine concentration and the gene expression of BDNF and bFGF in the rat brain","volume":"1179","author":"Follesa","year":"2007","journal-title":"Brain Res."},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Simard, S., Shail, P., MacGregor, J., El Sayed, M., Duman, R.S., Vaccarino, F.M., and Salmaso, N. (2018). Fibroblast growth factor 2 is necessary for the antidepressant effects of fluoxetine. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0204980"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.brainres.2008.05.088","article-title":"Antidepressant-like effects of intracerebroventricular FGF2 in rats","volume":"1224","author":"Turner","year":"2008","journal-title":"Brain Res."},{"key":"ref_57","first-page":"153","article-title":"Roles of exogenous and endogenous FGF-2 in animal models of depression","volume":"29","author":"Jarosik","year":"2011","journal-title":"Restor. Neurol. Neurosci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.biopsych.2012.03.003","article-title":"Antidepressant effects of fibroblast growth factor-2 in behavioral and cellular models of depression","volume":"72","author":"Elsayed","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Wang, L., Li, X.-X., Chen, X., Qin, X.-Y., Kardami, E., and Cheng, Y. (2018). Antidepressant-Like Effects of Low- and High-Molecular Weight FGF-2 on Chronic Unpredictable Mild Stress Mice. Front. Mol. Neurosci., 11.","DOI":"10.3389\/fnmol.2018.00377"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Tang, M.M., Lin, W.J., Pan, Y.Q., and Li, Y.C. (2018). Fibroblast Growth Factor 2 Modulates Hippocampal Microglia Activation in a Neuroinflammation Induced Model of Depression. Front. Cell Neurosci., 12.","DOI":"10.3389\/fncel.2018.00255"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.jad.2019.03.008","article-title":"Potential serum biomarkers for the prediction of the efficacy of escitalopram for treating depression","volume":"250","author":"Xu","year":"2019","journal-title":"J. Affect. Disord."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"110108","DOI":"10.1016\/j.intimp.2023.110108","article-title":"Serum cytokines-based biomarkers in the diagnosis and monitoring of therapeutic response in patients with major depressive disorder","volume":"118","author":"Xu","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"e1065","DOI":"10.1038\/tp.2017.31","article-title":"Altered peripheral immune profiles in treatment-resistant depression: Response to ketamine and prediction of treatment outcome","volume":"7","author":"Kiraly","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1093\/ijnp\/pyx060","article-title":"Platelet-Derived Growth Factor as an Antidepressant Treatment Selection Biomarker: Higher Levels Selectively Predict Better Outcomes with Bupropion-SSRI Combination","volume":"20","author":"Jha","year":"2017","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"111951","DOI":"10.1016\/j.jpsychores.2024.111951","article-title":"Major depressive disorder, neuroticism, suicidal behaviors, and depression severity are associated with cytokine networks and their intricate interactions with metabolic syndrome","volume":"187","author":"Maes","year":"2024","journal-title":"J. Psychosom. Res."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Wang, M., Wei, Z., Huang, Q., Yang, W., Wu, C., Cao, T., Zhao, J., Lyu, D., Wang, F., and Zhou, N. (2023). Prognostic prediction of subjective cognitive decline in major depressive disorder based on immune biomarkers: A prospective observational study. BMC Psychiatry, 23.","DOI":"10.1186\/s12888-022-04513-x"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.euroneuro.2009.06.006","article-title":"Effect of basic fibroblast growth factor (FGF2) gene polymorphisms on SSRIs treatment response and side effects","volume":"19","author":"Kato","year":"2009","journal-title":"Eur. Neuropsychopharmacol."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1038\/tp.2015.6","article-title":"Genetic variants in combination with early partial improvement as a clinical utility predictor of treatment outcome in major depressive disorder: The result of two pooled RCTs","volume":"5","author":"Kato","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.neuron.2012.08.037","article-title":"The fibroblast growth factor family: Neuromodulation of affective behavior","volume":"76","author":"Turner","year":"2012","journal-title":"Neuron"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"146596","DOI":"10.1016\/j.brainres.2019.146596","article-title":"The correlation between adiponectin and FGF9 in depression disorder","volume":"1729","author":"Wang","year":"2020","journal-title":"Brain Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.encep.2024.10.006","article-title":"Treatment resistant depression: A case of Muenke syndrome","volume":"51","author":"Cermolacce","year":"2025","journal-title":"Encephale"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00213-020-05699-2","article-title":"Carnosic acid alleviates depression-like behaviors on chronic mild stressed mice via PPAR-\u03b3-dependent regulation of ADPN\/FGF9 pathway","volume":"238","author":"Wang","year":"2021","journal-title":"Psychopharmacology"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/WNR.0000000000001591","article-title":"Expression of fibroblast growth factor 9 and its receptors in the dentate gyrus of hippocampus in poststroke depression rats","volume":"32","author":"Li","year":"2021","journal-title":"Neuroreport"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1097\/PSY.0000000000000953","article-title":"The Role of Fgf9 in the Antidepressant Effects of Exercise and Fluoxetine in Chronic Unpredictable Mild Stress Mice","volume":"83","author":"Xia","year":"2021","journal-title":"Psychosom. Med."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"7652","DOI":"10.1073\/pnas.0702225104","article-title":"Patterning of frontal cortex subdivisions by Fgf17","volume":"104","author":"Cholfin","year":"2007","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"104973","DOI":"10.1016\/j.ajp.2026.104973","article-title":"Reduced serum FGF17 levels are associated with deficits in motivation, pleasure, and expression in antidepressant-free patients with major depressive disorder","volume":"119","author":"Zhu","year":"2026","journal-title":"Asian J. Psychiatr."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ajhg.2007.09.021","article-title":"Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein","volume":"82","author":"Wang","year":"2008","journal-title":"Am. J. Hum. Genet."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s13041-018-0397-0","article-title":"Depressive symptoms are associated with a functional polymorphism in a miR-433 binding site in the FGF20 gene","volume":"11","author":"Adan","year":"2018","journal-title":"Mol. Brain."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/s41398-021-01679-y","article-title":"Fibroblast growth factor 21 (FGF21) is increased in MDD and interacts with body mass index (BMI) to affect depression trajectory","volume":"12","author":"Mason","year":"2022","journal-title":"Transl. Psychiatry"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.psychres.2017.01.075","article-title":"Negative correlation between cerebrospinal fluid FGF21 levels and BDI scores in male Chinese subjects","volume":"252","author":"Liu","year":"2017","journal-title":"Psychiatry Res."},{"key":"ref_81","doi-asserted-by":"crossref","unstructured":"Tang, M., Cheng, S., Wang, L., Tang, H., Liu, T., Zhao, T., and Dang, R. (2023). Decreased FGF19 and FGF21: Possible underlying common pathogenic mechanism of metabolic and cognitive dysregulation in depression. Front. Neurosci., 17.","DOI":"10.3389\/fnins.2023.1165443"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Wu, Y., Chen, Z., Duan, J., Huang, K., Zhu, B., Yang, L., and Zheng, L. (2021). Serum Levels of FGF21, \u03b2-Klotho, and BDNF in Stable Coronary Artery Disease Patients With Depressive Symptoms: A Cross-Sectional Single-Center Study. Front. Psychiatry, 11.","DOI":"10.3389\/fpsyt.2020.587492"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41398-024-03209-y","article-title":"Associations between biomarkers of inflammation and depressive symptoms-potential differences between diabetes types and symptom clusters of depression","volume":"15","author":"Herder","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"ref_84","doi-asserted-by":"crossref","unstructured":"Damanti, S., Sciorati, C., Avola, A., De Lorenzo, R., Brioni, E., Farina, F., Festorazzi, C., Laffranchi, M., Mallus, M., and Messina, M. (2026). Association between baseline circulating FGF21 levels and depressive symptoms at follow up in older adults: Evidence from the FRASNET cohort. Front. Psychiatry., 17.","DOI":"10.3389\/fpsyt.2026.1726636"},{"key":"ref_85","doi-asserted-by":"crossref","unstructured":"Wang, X., Zhu, L., Hu, J., Guo, R., Ye, S., Liu, F., Wang, D., Zhao, Y., Hu, A., and Wang, X. (2020). FGF21 Attenuated LPS-Induced Depressive-Like Behavior via Inhibiting the Inflammatory Pathway. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00154"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"e13026","DOI":"10.1111\/jne.13026","article-title":"Roles of fibroblast growth factor 21 in the control of depression-like behaviours after social defeat stress in male rodents","volume":"33","author":"Usui","year":"2021","journal-title":"J. Neuroendocrinol."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.cmet.2005.09.001","article-title":"Fibroblast growth factor 15 functions as an enterohepatic signal to regulate bile acid homeostasis","volume":"2","author":"Inagaki","year":"2005","journal-title":"Cell Metab."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1111\/j.1365-2796.2006.01731.x","article-title":"Circulating intestinal fibroblast growth factor 19 has a pronounced diurnal variation and modulates hepatic bile acid synthesis in man","volume":"260","author":"Angelin","year":"2006","journal-title":"J. Intern. Med."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"126","DOI":"10.4172\/Neuropsychiatry.1000187","article-title":"Is cerebrospinal fluid fibroblast growth factor 19 (FGF19) a mood regulator?","volume":"7","author":"Liu","year":"2017","journal-title":"Neuropsychiatry"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1017\/neu.2025.10028","article-title":"Association between fibroblast growth factor 19 and depressive symptoms: The moderating role of smoking","volume":"37","author":"Li","year":"2025","journal-title":"Acta Neuropsychiatr."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"107716","DOI":"10.1016\/j.psyneuen.2025.107716","article-title":"Association of circulating immune cell phenotypes and peripheral inflammatory biomarkers with depressive symptoms in the Framingham Heart Study","volume":"184","author":"Iyer","year":"2026","journal-title":"Psychoneuroendocrinology"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1172\/JCI200419081","article-title":"Targeted ablation of Fgf23 demonstrates an essential physiological role of FGF23 in phosphate and vitamin D metabolism","volume":"113","author":"Shimada","year":"2004","journal-title":"J. Clin. Invest."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/nature05315","article-title":"Klotho converts canonical FGF receptor into a specific receptor for FGF23","volume":"444","author":"Urakawa","year":"2006","journal-title":"Nature"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1002\/jnr.24312","article-title":"Inflammatory markers in women with postpartum depressive symptoms","volume":"98","author":"Fransson","year":"2020","journal-title":"J. Neurosci. Res."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"18445","DOI":"10.1038\/s41598-025-03543-1","article-title":"Plasma inflammation-related proteins associated with anxiety and depression disorders in IBD patients","volume":"15","author":"Zhou","year":"2025","journal-title":"Sci. Rep."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41398-025-03738-0","article-title":"Circulating inflammatory proteins associated with risks of schizophrenia, bipolar disorder, and major depressive disorder: A mendelian randomization study","volume":"16","author":"Dong","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bbr.2016.03.047","article-title":"Deletion of fibroblast growth factor 22 (FGF22) causes a depression-like phenotype in adult mice","volume":"307","author":"Williams","year":"2016","journal-title":"Behav. Brain Res."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/WNR.0000000000001399","article-title":"Neuronal fibroblast growth factor 22 signaling during development, but not in adults, is involved in anhedonia","volume":"31","author":"Terauchi","year":"2020","journal-title":"Neuroreport"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/cns.12760","article-title":"Fibroblast growth factor 22 is a novel modulator of depression through interleukin-1\u03b2","volume":"23","author":"Xu","year":"2017","journal-title":"CNS Neurosci. Ther."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"100860","DOI":"10.1016\/j.diff.2025.100860","article-title":"Fibroblast growth factor 22","volume":"143","author":"Furuta","year":"2025","journal-title":"Differentiation"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"154348","DOI":"10.1016\/j.bbrc.2026.154348","article-title":"FGF13 exerts neuroprotective effects via activation of the PI3K\/AKT signaling pathway and serves as a potential biomarker for depression","volume":"832","author":"Hu","year":"2026","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_102","doi-asserted-by":"crossref","unstructured":"Zheng, R., Zhang, Y., Tu, Z., Luo, Y., Lin, H., Chen, X., Huang, Z., Shao, L., Zheng, Y., and Wang, Z. (2026). FGF13 alleviates astrocytic apoptosis via JIP2 inhibition in the hippocampus and mitigates depression-like behavior. J. Neuroinflammation, Online ahead of print.","DOI":"10.1186\/s12974-026-03960-7"},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"19370","DOI":"10.1074\/jbc.M112.445924","article-title":"The fibroblast growth factor 14\u00b7voltage-gated sodium channel complex is a new target of glycogen synthase kinase 3 (GSK3)","volume":"288","author":"Shavkunov","year":"2013","journal-title":"J. Biol. Chem."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s40345-023-00314-7","article-title":"Differential diagnosis of unipolar versus bipolar depression by GSK3 levels in peripheral blood: A pilot experimental study","volume":"11","author":"Rosso","year":"2023","journal-title":"Int. J. Bipolar Disord."},{"key":"ref_105","doi-asserted-by":"crossref","unstructured":"Verbeek, E.C., Bakker, I.M., Bevova, M.R., Bochdanovits, Z., Rizzu, P., Sondervan, D., Willemsen, G., de Geus, E.J., Smit, J.H., and Penninx, B.W. (2012). A fine-mapping study of 7 top scoring genes from a GWAS for major depressive disorder. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0037384"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/s41398-025-03361-z","article-title":"Deletion of Fgf14 confers resilience to basal and stress-induced depressive-like behavior and reduces anxiety in mice","volume":"15","author":"Montarolo","year":"2025","journal-title":"Transl. Psychiatry"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1093\/schbul\/sbp033","article-title":"Fibroblast growth factors in schizophrenia","volume":"36","author":"Bakker","year":"2010","journal-title":"Schizophr. Bull."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1523\/JNEUROSCI.5285-03.2004","article-title":"Loss of glutamatergic pyramidal neurons in frontal and temporal cortex resulting from attenuation of FGFR1 signaling is associated with spontaneous hyperactivity in mice","volume":"24","author":"Shin","year":"2004","journal-title":"J. Neurosci."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.neures.2007.10.010","article-title":"Gene expression profiling of major depression and suicide in the prefrontal cortex of postmortem brains","volume":"60","author":"Tochigi","year":"2008","journal-title":"Neurosci. Res."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.pnpbp.2012.12.010","article-title":"Gene expression analysis of novel genes in the prefrontal cortex of major depressive disorder subjects","volume":"43","author":"Goswami","year":"2013","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.neulet.2007.10.041","article-title":"The fibroblast growth factor system is downregulated following social defeat","volume":"430","author":"Turner","year":"2008","journal-title":"Neurosci. Lett."},{"key":"ref_112","first-page":"3","article-title":"Analysis of genes linked to depressive-like behaviors in interleukin-18-deficient mice: Gene expression profiles in the brain","volume":"12","author":"Yamanishi","year":"2020","journal-title":"Biomed. Rep."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.tins.2015.11.003","article-title":"FGFR1\u20135-HT1A Heteroreceptor Complexes: Implications for Understanding and Treating Major Depression","volume":"39","author":"Tarakanov","year":"2016","journal-title":"Trends Neurosci."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.biopsych.2011.09.012","article-title":"Fibroblast growth factor receptor 1- 5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity","volume":"71","author":"Ciruela","year":"2012","journal-title":"Biol. Psychiatry"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.bbrc.2015.04.133","article-title":"Enhancement of the FGFR1 signaling in the FGFR1-5-HT1A heteroreceptor complex in midbrain raphe 5-HT neuron systems. Relevance for neuroplasticity and depression","volume":"463","author":"Narvaez","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Borroto-Escuela, D.O., DuPont, C.M., Li, X., Savelli, D., Lattanzi, D., Srivastava, I., Narv\u00e1ez, M., Di Palma, M., Barbieri, E., and Andrade-Talavera, Y. (2017). Disturbances in the FGFR1-5-HT1A Heteroreceptor Complexes in the Raphe-Hippocampal 5-HT System Develop in a Genetic Rat Model of Depression. Front. Cell Neurosci., 11.","DOI":"10.3389\/fncel.2017.00309"},{"key":"ref_117","doi-asserted-by":"crossref","unstructured":"Ambrogini, P., Lattanzi, D., Pagliarini, M., Di Palma, M., Sartini, S., Cuppini, R., Fuxe, K., and Borroto-Escuela, D.O. (2023). 5HT1AR-FGFR1 Heteroreceptor Complexes Differently Modulate GIRK Currents in the Dorsal Hippocampus and the Dorsal Raphe Serotonin Nucleus of Control Rats and of a Genetic Rat Model of Depression. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24087467"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1038\/s41386-018-0117-6","article-title":"Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression","volume":"43","author":"Carboni","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1460-9568.2008.06471.x","article-title":"Depression-like behaviour in neural cell adhesion molecule (NCAM)-deficient mice and its reversal by an NCAM-derived peptide, FGL","volume":"28","author":"Jurgenson","year":"2008","journal-title":"Eur. J. Neurosci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1038\/s12276-025-01519-9","article-title":"Dysregulation of FGFR1 signaling in the hippocampus facilitates depressive disorder","volume":"57","author":"Shin","year":"2025","journal-title":"Exp. Mol. Med."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1038\/mp.2010.44","article-title":"Altered expression of glutamate signaling, growth factor, and glia genes in the locus coeruleus of patients with major depression","volume":"16","author":"Bernard","year":"2011","journal-title":"Mol. Psychiatry."},{"key":"ref_122","doi-asserted-by":"crossref","unstructured":"Carboni, L., Pischedda, F., Piccoli, G., Lauria, M., Musazzi, L., Popoli, M., Math\u00e9, A.A., and Domenici, E. (2020). Depression-Associated Gene Negr1-Fgfr2 Pathway Is Altered by Antidepressant Treatment. Cells, 9.","DOI":"10.3390\/cells9081818"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8464\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T08:17:54Z","timestamp":1790151474000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/19\/8464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,23]]},"references-count":122,"journal-issue":{"issue":"19","published-online":{"date-parts":[[2026,10]]}},"alternative-id":["ijms27198464"],"URL":"https:\/\/doi.org\/10.3390\/ijms27198464","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,23]]}}}